NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission last week, CareDx announced that its CareDx Pty subsidiary had agreed to purchase from Illumina affiliate Conexio Genomics certain property and assets related to HLA typing for sequencing using capillary electrophoresis-based methods.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.